Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,020.00
Bid: 1,032.00
Ask: 1,037.00
Change: 12.00 (1.19%)
Spread: 5.00 (0.484%)
Open: 990.00
High: 1,037.00
Low: 980.50
Prev. Close: 1,008.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Dec 2011 07:00

RNS Number : 7250T
Burford Capital
12 December 2011
 



Burford Capital Limited

 

Burford reports continued activity and entry into UK market

 

Acquisition of leading UK litigation insurance provider to form basis for market entry

 

12 December 2011

 

Burford Capital Limited ("Burford Capital" or "Burford" or "the Company"), the world's largest provider of investment capital and risk solutions for litigation, today reports the following developments:

 

Highlights: 

·; Burford is entering the UK litigation funding market, consistent with its recent statement to shareholders that it was ready to expand into markets beyond the US, while retaining a substantial focus on and leadership in the US market

 

·; Burford has entered into a conditional agreement to acquire Firstassist Legal Expenses ("Firstassist"), the UK's leading after-the-event (ATE) litigation insurance provider, for cash consideration of £10.3 million ($16.1 million1) at closing plus a deferred element contingent on future performance

 

·; With Firstassist's existing business, market-leading management team and significant legal network, Burford intends to build a leading UK litigation funding business with unrivalled scale, in a market it finds increasingly attractive in light of the proposed Jackson reforms

 

·; Sir Peter Middleton, GCB, Burford's Chairman, will also become the Chairman of the parent company in the Firstassist group

 

·; The transaction is attractively priced, funded entirely by available cash and is expected to be immediately earnings accretive for Burford

 

·; Burford's investment activity in its existing US litigation and international arbitration business continues to progress well, with $35 million in new commitments made in the last three months and a further complete resolution of a short duration matter

Firstassist

 

Firstassist Legal Expenses is the leading provider of after-the-event litigation insurance in the UK.2 It is presently owned by Equistone Partners (until recently Barclays Private Equity), and it issues insurance policies on behalf of a subsidiary of Munich Re. Its primary focus and the main driver of its growth is high value cases. The group consists of 32 professionals, including a large underwriting division and a sales team of six.

 

Firstassist has a robust track record of growth and profitability and has a current book of over 3,000 cases under cover. Firstassist expects 2011 EBITDA in excess of £6 million ($9.4 million).

 

Rationale

 

Burford has always been clear in its intention to expand into other markets if the opportunity was right, stating in its AIM admission document that "in the medium-term, the Company may expand its focus to other attractive and suitable jurisdictions" and announcing in its September 2011 interim report that it was ready to undertake that expansion. The UK market is a logical expansion target. The UK common law market - second in size only to the US - has been steadily embracing alternative litigation finance and other legal reforms, so that it has now become one of the most hospitable environments for litigation funding, with a substantial litigation volume.

 

Regulatory reform has hastened this process: pending legislation will tilt the playing field still further in favour of litigation funding. It is no coincidence that other players have announced their entry or expansion into the market, but none has the scale of Burford.

 

The pending reforms will also change the landscape for ATE insurance, principally by eliminating recoverability of premiums as a "cost" of litigation. The differing impact of those reforms on the ATE market is still uncertain. Small personal injury matters are likely to be very negatively affected but larger commercial matters (Burford's and Firstassist's main emphasis) less so and in fact this area of the market is showing prospects for continued growth.

 

Synergies

 

The transaction provides significant benefits to Burford. The acquisition is attractively priced and structured at a multiple that reflects the uncertainty associated with the Jackson reforms on the ATE business. Through it, Burford gains the services and brand of a leading team to launch an aggressive push into third party funding as an adjunct to, and hedge for, the ATE business. The acquisition is expected to be significantly earnings-enhancing in 2012 and to produce the leading UK provider of litigation capital and insurance solutions.

 

The combination of Firstassist and Burford is also compelling for strategic reasons. Burford gains an existing business with 32 employees, a solid track record of growth and profitability, a sales platform and relationships with hundreds of law firms that can both continue to write ATE coverage and also expand with Burford to offer capital to those law firms to fund cases. Firstassist gains the capital and expertise of the world's largest litigation funder.

 

Transaction

 

Burford will acquire Firstassist Legal Group Holdings Limited, the parent company of all companies in the Firstassist Legal Expenses group, and Sir Peter Middleton, GCB, will become Chairman of that entity. The transaction structure involving the entities below the parent is the subject of ongoing legal and tax study. The transaction is subject to FSA approval and is expected to close in the first quarter of 2012.

 

The transaction structure includes:

 

- A payment of £10.3 million ($16.1 million) cash at closing on a debt-free basis and with the business delivered with £3 million ($4.7 million) of net cash on hand

- Burford will pay up to £7 million ($10.9 million) in an earn-out payment in 2014, which is dependent on Firstassist achieving a combined EBITDA target for 2012 and 2013 of £19.3 million ($30.2 million) or more

- A lower earn out will be triggered if the EBITDA target is not reached and the earn-out mechanism ceases if the combined EBITDA is below £14.5 million ($22.7 million) or if the business' volume of new insurance coverage written declines substantially

 

Christopher Bogart, Chief Executive Officer, Burford Group, commented: "Extending our footprint into the UK third party litigation market has always been a strategic goal for Burford and I'm delighted to achieve it through the acquisition of the UK's leading litigation insurance provider, Firstassist.

 

"The scale and quality of Firstassist's litigation insurance offering, combined with its industry-leading management and strong legal network, provide Burford with an exciting platform to build a unique litigation capital and insurance solutions group, which we hope will thrive in the increasingly attractive and growing UK market.

 

"The acquisition will complement the continued performance of the existing portfolio and we look forward to 2012 and the opportunities ahead with confidence."

 

Peter Smith, Managing Director, Firstassist Legal Expenses said: "We are delighted to be combining the UK's leading ATE insurance business with the world's leading litigation financier. Together, we will build the pre-eminent UK litigation funding business while continuing the historical growth of Firstassist's ATE insurance business."

 

Progress on the existing portfolio

 

Since its last update on 7 September 2011, Burford has committed a further $35 million to three new core investments.3 The Company can provide the following updates on the existing portfolio.

 

·; Burford previously indicated that a case in the short duration portfolio had experienced a positive appeal result. The defendant in that case elected to seek a further level of appellate review which it subsequently lost, and has paid the judgment against it. Burford has thus received its $4.5 million portion of that payment (from its $2 million investment made in early 2010), representing an IRR of more than 50%.

 

·; There have been publicly reported settlement discussions in another of the Company's short duration cases. If consummated in the ranges discussed, an IRR of 49% is expected on an $8 million investment, continuing until the date paid.

 

·; In two of Burford's core investments, interlocutory appeals of dispositive motions have been resolved in favour of the parties to whom the Company is providing financing, resulting in those matters now being returned to aggressive pre-trial schedules and presumably dampening the opponents' hopes to avoid meaningful payments.

 

·; Burford's last trading update included a $10 million commitment in a core matter. This matter - a large commercial insolvency - was later able to obtain release of its own frozen funds in lieu of financing, and thus the trustee of the insolvent estate unwound the commitment. The estate was obliged to pay a $340,000 break fee to Burford in that regard, which has been received and will be included in income.

 

·; It has been reported in the media that a subsidiary of Burford provided financing to a pending case against Chevron Corporation in connection with a large oil spill in Ecuador. In fact, a Burford subsidiary entered into an arrangement to provide financing directly (and only) to a major US law firm in connection with that case. Burford provided $4 million of such financing to the law firm in November 2010, but sold a $4 million participation in the investment to a third party in December 2010. Thus, Burford has no risk in the matter but does retain a residual interest in the outcome. Originally, the potential maximum financing commitment - at Burford's option - was up to $15 million, and was included as such in the special situations portfolio. Further developments have led Burford to conclude that no further financing will be provided and thus decide to reduce the commitment level in the special situations portfolio accordingly.

 

Christopher Bogart, Chief Executive Officer, Burford Group, commented: "We are very pleased with the current performance and outlook for our portfolio. The previously reported performance of the short duration portfolio proved out the model, and the core portfolio continues to develop in an encouraging way. Burford also continues to see an ever-increasing variety of investment opportunities, and in addition to single investments we are actively pursuing portfolio investments that permit opportunities to secure returns with lower binary risk. Indeed, more than half our investment capital in the most recent quarter has been committed in investments where more than one defendant or one claim underpins our investment."

 

For further information, please contact:

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

Steve Baldwin +44 (0)20 3037 2000

Nicholas Harland

Espirito Santo Investment Bank - Joint Broker

Richard Crawley +44 (0)20 7456 9191

FTI Consulting - PR for Burford Capital

Edward Berry +44 (0)20 7269 7297

Laura Pope +44 (0)20 7269 7243

 

About Burford

 

Burford is the world's largest provider of investment capital and risk solutions for litigation.

 

Burford Capital Limited is a closed-end $300 million investment fund publicly traded on the London Stock Exchange's Alternative Investment Market under the ticker symbol BUR. Burford provides a broad range of corporate finance solutions to lawyers and clients engaged in significant litigation and arbitration around the world. Burford Group Limited serves as the investment adviser to Burford Capital and has an expert team drawn from major law firms and corporations.

 

For more information about Burford: www.burfordfinance.com.

 

 

 

1£ / US$ exchange rate of 1.563

2 The acquisition should not be confused with the separate before-the-event litigation insurer that trades as FirstAssist Legal Protection which was recently sold by Equistone to Cigna. Further information on Firstassist Legal Expenses can be found at www.legalexpenses.co.uk.

3In one of the new investment commitments, Burford's counterparty has the ability to elect a smaller commitment from Burford by as much as $10 million. We have reported what we believe to be the most likely outcome.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEASANELFFFFF
Date   Source Headline
31st Aug 20232:00 pmRNSNotice of 2Q23 Results Call Details
25th Aug 20237:00 amRNSUS SEC Closes Comment Letter Review
9th Aug 20232:00 pmRNSDirector/PDMR Shareholding
12th Jul 202310:37 amRNSResult of AGM
7th Jul 202312:45 pmRNSPricing of Early Redemption of 2024 Bonds
4th Jul 20235:00 pmRNSTransaction in Own Shares
3rd Jul 20232:00 pmRNSCompletion of Share Purchases & PDMR Transactions
29th Jun 202311:14 amRNSIntended Purchases of Ordinary Shares
26th Jun 20236:00 pmRNSDirector/PDMR Shareholding
26th Jun 20232:08 pmRNSUpdate & Release Date for 2Q23 Results
26th Jun 20232:07 pmRNSNotice of Early Redemption of Bonds due 2024
26th Jun 20232:05 pmRNSClosing of Private Offering of Senior Notes
23rd Jun 20237:00 amRNSPricing of Senior Notes Offering
22nd Jun 20235:22 pmRNSDirector/PDMR Shareholding
20th Jun 20231:00 pmRNSPrivate Offering of Senior Notes
13th Jun 202312:00 pmRNS1Q23 Results & Quarterly Report
8th Jun 20233:00 pmRNSNotice of 1Q23 Results & Results Call Details
6th Jun 202312:00 pmRNSNotice of Retail Shareholder Call on June 21, 2023
6th Jun 202312:00 pmRNSNotice of 2023 AGM
2nd Jun 202312:00 pmRNSSterling FX Rate for Second 2022 Interim Dividend
16th May 202312:00 pmRNSAvailability of 2022 Annual Report
16th May 202312:00 pmRNSAnnual results for year ended December 31, 2022
3rd May 20237:00 amRNSNotice of 2022 Results and Update on Accounting
3rd Apr 20237:30 amRNSRestoration - Burford Capital Limited
3rd Apr 20237:00 amRNSStatement on YPF Summary Judgment Ruling
31st Mar 20234:57 pmRNSSuspension - Burford Capital Limited
31st Mar 20234:14 pmRNSStatement re Petersen and Eton Park Matters
29th Mar 20233:00 pmRNSTransaction in Own Shares
22nd Mar 20234:00 pmRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSUpdate on 2022 Business Activity
3rd Jan 202312:00 pmRNSUpdate on and Completion of Share Purchases by EBT
30th Dec 20221:13 pmRNSDirector/PDMR Shareholding
28th Dec 202212:00 pmRNSUpdate on Share Purchases by EBT
16th Dec 202212:00 pmRNSUpdate on Share Purchases by EBT
9th Dec 20225:00 pmRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSIntended Share Purchases by Employee Benefit Trust
25th Nov 202212:00 pmRNSDirector/PDMR Bondholding
16th Nov 202212:00 pmRNSAppointment of Joint Corporate Broker
9th Nov 202212:00 pmRNSSterling FX Rate for 2022 Interim Dividend
1st Nov 20221:23 pmRNSBurford Capital Releases 2022 GC Survey Results
13th Sep 20223:27 pmRNSBurford Capital-Report on Class Action Recoveries
6th Sep 20227:00 amRNSJordan Licht Appointed Chief Financial Officer
26th Aug 20222:00 pmRNSDirector/PDMR Shareholding
24th Aug 20222:00 pmRNSDirector/PDMR Shareholding
16th Aug 20222:00 pmRNSPDMR Shareholding and Transaction in Own Shares
9th Aug 202212:01 pmRNSDr. Rukia Baruti Appointed as Board Director
9th Aug 202212:00 pmRNSInterim Results for six months ended 30 June 2022
26th Jul 20222:00 pmRNSTR-1: Notification of Major Holdings
26th Jul 202212:00 pmRNSNotice of 1H22 Results Date & Results Call Details
25th Jul 20222:00 pmRNSTR-1: Notification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.